Esomeprazole 相關新聞

← 返回新聞總覽


Esomeprazole 目前有 0 則相關新聞報導,預測適應症 20 個。

本頁整合 Esomeprazole 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
  • 原適應症:Nexium Control is indicated for the short-term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults.
  • 證據等級:L5
  • 預測適應症(20 個):
    • gastrin secretion abnormality(99.8%)
    • peptic esophagitis(99.6%)
    • duodenogastric reflux(99.5%)
    • duodenal obstruction(99.5%)
    • duodenal ulcer (disease)(99.4%)
    • Zollinger-Ellison syndrome(99.2%)
    • active peptic ulcer disease(99.0%)
    • abnormality of glucagon secretion(99.0%)
    • peptic ulcer perforation(98.9%)
    • gastrojejunal ulcer(98.9%)
    • esophagitis (disease)(97.9%)
    • Smouldering systemic mastocytosis(97.0%)
    • multiple endocrine neoplasia(96.7%)
    • acne (disease)(96.6%)
    • lymphoadenopathic mastocytosis with eosinophilia(96.3%)
    • gastroduodenitis(95.7%)
    • systemic mastocytosis(94.2%)
    • gastric ulcer (disease)(93.9%)
    • duodenitis(93.1%)
    • peptic ulcer disease(92.6%)

查看完整藥物報告 →

相關新聞(0 則)

目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。

免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。

Copyright © 2026 EuTxGNN Project. For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.